Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Aberdeen Latin American Income Fund

19 Aug 2019 12:12

RNS Number : 5115J
Aberdeen Latin American Inc Fd Ltd
19 August 2019
 

 

London, UK, 19 August 2019

Edison issues review on Aberdeen Latin American Income Fund (ALAI)

Aberdeen Latin American Income Fund (ALAI) offers broad exposure to Latin America (both equities and government debt). It is managed by Aberdeen Standard Investments' (ASI's) well-resourced global emerging markets equities and emerging market debt teams. They are cautiously optimistic on the outlook for Latin America, believing the continued low interest-rate environment is supportive for corporate earnings growth and has the potential to stimulate investor demand for attractively valued assets in the region. ALAI has generated solid double-digit annualised NAV and share price total returns over the last three years, with particularly strong absolute and relative performance in the last 12 months. The fund offers an attractive 4.9% dividend yield.

 

ALAI's current 14.0% share price discount to cum-income NAV compares with the 12.2% to 14.1% range of average discounts over the last one, three and five years. The board has maintained the fund's dividend at 3.5p per share for the last three financial years (current yield of 4.9%). Gearing of up to 20% of NAV is permitted; net gearing was 11.3% at end-June 2019.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttruts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRALLFLLTIIALIA
Date   Source Headline
13th Jun 20236:00 pmRNSAbrdn Latin American Income Fund
12th Jun 20231:05 pmRNSResult of EGM
12th Jun 20237:30 amRNSSuspension-abrdn Latin American Income Fund
9th Jun 202312:35 pmRNSNet Asset Value(s)
9th Jun 202310:33 amRNSRepayment and Cancellation of Loan Facility
8th Jun 202312:45 pmRNSNet Asset Value(s)
7th Jun 20234:46 pmRNSHolding(s) in Company
7th Jun 202312:01 pmRNSNet Asset Value(s)
7th Jun 202310:55 amRNSMonth End Net Asset Value(s)
6th Jun 202312:13 pmRNSNet Asset Value(s)
5th Jun 20234:18 pmRNSNet Asset Value(s)
2nd Jun 20233:39 pmRNSQuarterly disclosure
2nd Jun 20231:22 pmRNSNet Asset Value(s)
31st May 20231:28 pmRNSNet Asset Value(s)
30th May 20233:54 pmRNSGearing disclosure
30th May 20233:47 pmRNSHolding(s) in Company
30th May 202312:51 pmRNSNet Asset Value(s)
26th May 202312:38 pmRNSNet Asset Value(s)
25th May 20233:55 pmRNSHolding(s) in Company
25th May 202312:34 pmRNSNet Asset Value(s)
24th May 202311:59 amRNSNet Asset Value(s)
23rd May 202312:21 pmRNSNet Asset Value(s)
22nd May 20233:21 pmRNSGearing disclosure
22nd May 202312:25 pmRNSNet Asset Value(s)
19th May 20231:49 pmRNSNet Asset Value(s)
18th May 202312:50 pmRNSNet Asset Value(s)
18th May 202310:14 amRNSPortfolio disclosure
18th May 20237:00 amRNSRecommended Proposals for Winding-Up of Company
17th May 202312:37 pmRNSNet Asset Value(s)
16th May 202312:06 pmRNSNet Asset Value(s)
15th May 20232:55 pmRNSGearing disclosure
15th May 202311:41 amRNSNet Asset Value(s)
12th May 202312:14 pmRNSNet Asset Value(s)
11th May 202312:35 pmRNSNet Asset Value(s)
11th May 202311:57 amRNSHolding(s) in Company
10th May 20231:07 pmRNSNet Asset Value(s)
9th May 20235:38 pmRNSGearing disclosure
9th May 202311:53 amRNSNet Asset Value(s)
5th May 20236:15 pmRNSMonth End Net Asset Value(s)
5th May 20231:12 pmRNSNet Asset Value(s)
4th May 202312:36 pmRNSNet Asset Value(s)
3rd May 202312:44 pmRNSNet Asset Value(s)
2nd May 20234:05 pmRNSGearing disclosure
28th Apr 20231:00 pmRNSNet Asset Value(s)
27th Apr 20231:17 pmRNSNet Asset Value(s)
26th Apr 20231:12 pmRNSNet Asset Value(s)
25th Apr 202312:45 pmRNSNet Asset Value(s)
24th Apr 20232:26 pmRNSGearing disclosure
24th Apr 202312:19 pmRNSNet Asset Value(s)
21st Apr 202312:58 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.